Helen Booler

Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease

Gai Ayalon, Seung-Hye Lee, Oskar Adolfsson et al. · Science Translational Medicine · 2021 · 111 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Conjunctival bacterial and fungal flora in healthy horses in the UK

Imogen Johns, Katherine Baxter, Helen Booler et al. · Veterinary Ophthalmology · 2011 · 73 citations · Full text

Medicine, Microbiology, Veterinary Microbiology +17

Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation

Helen Prior, Paul Baldrick, Sonja Beken et al. · Regulatory Toxicology and Pharmacology · 2020 · 40 citations · Full text

Pharmacy, Pharmacology, Toxicology +16

The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice

C. Whitmore, Marta Fernández-Fuente, Helen Booler et al. · Human Molecular Genetics · 2013 · 36 citations · Full text

Medicine, Genetics, Neurology +15

Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eye

Whitney Shatz-Binder, Philip E. Hass, Nikhil Peer et al. · PLoS ONE · 2019 · 28 citations · Full text

Pharmacy, Ophthalmology, Pharmaceutics +17